Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,78119,800 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Mobile Ecological Momentary Diet Assessment: A Low Burden, Ecologically-Valid Approach to Measuring Dietary Intake in Near-Real Time
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2022

ABSTRACT The excessive intake of saturated fat and added sugars has been identified as a leading cause of premature mortality among adults in the U.S. contributing to approximately...

$10
USD
Completed NON-SBIR/STTR RPGS
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
NATIONAL CANCER INSTITUTE Texas A&M University Health Science Ctr United States 2021 – 2026

Project Summary/Abstract Current AR inhibitors (enzalutamide and abiraterone) inhibit either the conversion of androgen to dihydrotestosterone (DHT), block androgen binding to andr...

$4.49M
USD
Completed OTHER RESEARCH-RELATED
Regulators of ubiquitin signaling in malignant hematopoiesis
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2025

Project Summary / Abstract Myelodysplastic syndromes (MDS) are heterogeneous clonal hematopoietic stem and progenitor cell (HSPC) disorders with frequent transformation to acute my...

$863.3K
USD
Completed NON-SBIR/STTR RPGS
Energy Balance, mTOR pathway signaling, and breast cancer prognosis
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

Project Summary/Abstract The objective of this project is to understand the role of the mechanistic Target of Rapamycin (mTOR) pathway in the association between energy imbalance a...

$3.28M
USD
Completed NON-SBIR/STTR RPGS
Targeting vulnerabilities of PPM1D-mutant gliomas
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary/Abstract Diffuse midline gliomas (DMGs) are devastating brain tumors of childhood with no curative treatments. We and others have observed up to 15% of all DMGs to...

$4.04M
USD
Completed NON-SBIR/STTR RPGS
Re-purposing beta-blockers to improve chemotherapy response
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2024

ABSTRACT Metastatic tumors often develop chemoresistance, which makes chemotherapy ineffective. We have exciting evidence that beta-blockers, which are widely used cardiac drugs, c...

$1.79M
USD
Completed NON-SBIR/STTR RPGS
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
NATIONAL CANCER INSTITUTE George Washington University United States 2021 – 2023

Project Summary The median survival for metastatic melanoma is approximately 8–16 months, and few therapies offer a significant improvement in overall survival. However, immunother...

$1.04M
USD
Completed NON-SBIR/STTR RPGS
A large animal model to elucidate the role of LGR5 stem cells in cancer
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2024

Project Summary In the United States, colorectal cancer (CRC) is the 3rd leading cause of cancer death among women and men combined, with of 1 in 20 people being diagnosed with CRC...

$1.74M
USD
Completed NON-SBIR/STTR RPGS
Energy Balance, mTOR pathway signaling, and breast cancer prognosis
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2022

Project Summary/Abstract The objective of this project is to understand the role of the mechanistic Target of Rapamycin (mTOR) pathway in the association between energy imbalance a...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
Polyunsaturated fatty acids and colorectal tumor risk: a molecular and genetic epidemiology study
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Arachidonic acid, a long-chain ω-6 polyunsaturated fatty acid (PUFA), has been demonstrated to affect carcinogenesis in animal and in vitro studies. The ef...

$2.48M
USD
Completed NON-SBIR/STTR RPGS
The role of PARP10 in alleviating replication stress and promoting cellular proliferation and tumorigenesis
NATIONAL CANCER INSTITUTE Pennsylvania State University Hershey Me... United States 2021 – 2026

Project Summary Identification of molecular pathways that are preferentially employed and relied upon by cancer cells compared to normal cells is key to designing novel personalize...

$3.61M
USD
Completed NON-SBIR/STTR RPGS
Development of next generation 2HG and metabolic MR imaging for precision oncology of mutant IDH and wildtype glioma patients
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

7. Project Summary/Abstract Gliomas are rarely curable tumors with a low survival rate of 36% at five-years that is well below the average survival rate of 67.2% across all cancers...

$5.61M
USD
Completed SBIR-STTR RPGS
Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia
NATIONAL CANCER INSTITUTE Cooler Heads Care Inc United States 2021 – 2024

PROJECT SUMMARY—Approximately two-thirds of patients undergoing cancer treatment experience hair loss from chemotherapy-induced alopecia (CIA). Patients say CIA is one of the most...

$10.33M
USD
Completed OTHER RESEARCH-RELATED
Improving sleep in gynecologic cancer survivors
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY Sleep disturbance is one of the primary complaints of gynecologic cancer survivors, with more than 80% of survivors reporting sleep difficulties. Sleep disturbance...

$2.29M
USD
Completed OTHER RESEARCH-RELATED
Surgical Multispecialty Access to Research in Residency Training (SMART)
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2025

SUMMARY Surgeon-scientists are an underrepresented population in academic medicine, and federally funded surgeon- scientist-led research has been in decline over the past decade. S...

$2.52M
USD
Completed NON-SBIR/STTR RPGS
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Project Summary The lack of specific targets for the treatment of triple-negative breast cancer (TNBC) is a major challenge, as many TNBCs do not respond to cytotoxic chemotherapie...

$3.62M
USD
Completed NON-SBIR/STTR RPGS
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

SUMMARY/ABSTRACT Immune checkpoint inhibitors (ICIs) have transformed the management of patients with metastatic non-small cell lung cancer (NSCLC). Unfortunately, over 50% of pati...

$3.8M
USD
Completed NON-SBIR/STTR RPGS
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

SUMMARY / ABSTRACT With current treatment options, the five-year survival rate of patients with glioblastoma (GBM) is only 5%. Oncolytic viruses are promising treatments against so...

$3.52M
USD
Completed NON-SBIR/STTR RPGS
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2026

Project Summary/Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood. Despite rigorous clinical trials the survival for children with high-risk RMS h...

$3.9M
USD
Completed NON-SBIR/STTR RPGS
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Project Summary The lack of specific targets for the treatment of triple-negative breast cancer (TNBC) is a major challenge, as many TNBCs do not respond to cytotoxic chemotherapie...

$3.51M
USD